HLA-G Expression in Human Breast Cancer: Implications for Diagnosis and Prognosis, and Effect on Allocytotoxic Lymphocyte Response After Hormone Treatment In Vitro-Reference-Cited by-同舟云学术

HLA-G Expression in Human Breast Cancer: Implications for Diagnosis and Prognosis, and Effect on Allocytotoxic Lymphocyte Response After Hormone Treatment In Vitro

Published:2010-01-06 Issue:5 Volume:17 Page:1459-1469
ISSN:1068-9265
Container-title:Annals of Surgical Oncology
language:en
Short-container-title:Ann Surg Oncol

Author:

He Xu,Dong Dan-dan,Yie Shang-mian,Yang Hong,Cao Mei,Ye Shang-rong,Li Ke,Liu Ji,Chen Jie

Publisher

Springer Science and Business Media LLC

Subject

Oncology,Surgery

Link

http://link.springer.com/content/pdf/10.1245/s10434-009-0891-9.pdf

Reference32 articles.

1. LeMaoult J, Rouas-Freiss N, Carosella ED. Immuno-tolerogenic functions of HLA-G: relevance in transplantation and oncology. Autoimmun Rev. 2005;4:503–9.

2. Carosella ED, Moreau P, Lemaoult J, Rouas-Freiss N. HLA-G: from biology to clinical benefits. Trends Immunol. 2008;29:125–32.

3. Ye SR, Yang H, Li K, Dong DD, Lin XM, Yie SM. Human leukocyte antigen G expression: as a significant prognostic indicator for patients with colorectal cancer. Mod Pathol. 2007;20:375–83.

4. Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM. Expression of HLA-G is associated with prognosis in esophageal squamous cell carcinoma. Am J Clin Pathol. 2007;128:1002–9.

5. Yie SM, Yang H, Ye SR, Li K, Dong DD, Lin XM. Expression of human leucocyte antigen G (HLA-G) is associated with prognosis in non-small cell lung cancer. Lung Cancer. 2007;58:267–74.

Cited by 90 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Strategies for Overcoming Immune Evasion in Bladder Cancer;International Journal of Molecular Sciences;2024-03-07

2. Harnessing the potential of HLA-G in cancer therapy: advances, challenges, and prospects;Journal of Translational Medicine;2024-02-03

3. Elevated sHLA-G plasma levels post chemotherapy combined with ILT-2 rs10416697C allele status of the sHLA-G-related receptor predict poorest disease outcome in early triple-negative breast cancer patients;Frontiers in Immunology;2023-05-22

4. Human leukocyte antigen and tumor immunotherapy (Review);International Journal of Oncology;2023-04-26

5. Extreme structural heterogeneity rewires glioblastoma chromosomes to sustain patient-specific transcriptional programs;2023-04-21